Skip to main content
Livermore
Livermore
ZHEN

Wealthspire Advisors, LLC

SEC CIK
0001646247
Latest filing
Aug 11, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by Wealthspire Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q2 2026)
16,207
Value
$776.9K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NVO by Wealthspire Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202616,207$776.9K<0.1%+3,702+29.6%AddedHolders
Q1 202612,505$459.6K<0.1%−2,947−19.1%ReducedHolders
Q4 202515,452$786.2K<0.1%−13,936−47.4%ReducedHolders
Q3 202529,388$1.63M<0.1%+2,296+8.5%AddedHolders
Q2 202527,092$1.87M<0.1%+1,208+4.7%AddedHolders
Q1 202525,884$1.80M<0.1%+13,009+101.0%AddedHolders
Q4 202412,875$1.11M<0.1%−3,013−19.0%ReducedHolders
Q3 202415,888$1.89M<0.1%+6,843+75.7%AddedHolders
Q2 20249,045$1.29M<0.1%−97−1.1%ReducedHolders
Q1 20249,142$1.17M<0.1%+1,261+16.0%AddedHolders
Q4 20237,881$815.3K<0.1%−611−7.2%ReducedHolders
Q3 20238,492$772.3K<0.1%+1,794+26.8%AddedConverted for a 2-for-1 splitHolders
Q2 20233,349$542.0K<0.1%+209+6.7%AddedHolders
Q1 20233,140$499.7K<0.1%−1,988−38.8%ReducedHolders
Q4 20225,128$694.0K<0.1%+1,635+46.8%AddedHolders
Q3 20223,493$348.0K<0.1%+814+30.4%AddedHolders
Q2 20222,679$299.0K<0.1%−50−1.8%ReducedHolders
Q1 20222,729$303.0K<0.1%−1,941−41.6%ReducedHolders
Q4 20214,670$523.0K<0.1%−297−6.0%ReducedHolders
Q3 20214,967$477.0K<0.1%+1,345+37.1%AddedHolders
Q2 20213,622$303.0K<0.1%−1,716−32.1%ReducedHolders
Q1 20215,338$360.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.